The expression of PAD2 is crucial for the survival, cell cycle development, and proliferation of prostate cancer cells.32, 33, 34, 35 Therefore, PAD2-mediated histone citrullination may become a potential target for the treatment of prostate cancer.32 Here, PADI2 is linked to prostate carcinoma.